Organised by ESMO in partnership with the EACR
23 - 24 March 2018 || Vall d’Hebron Institute of Oncology, Barcelona, Spain
The 6th edition of the ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), will focus on Cyclin-dependent kinases (CDKs).
It is the next important step in a strategic collaboration between basic scientists and translational and clinical researchers. The aim is to foster close cooperation among academics, clinical and industry researchers in a highly interactive hands-on professional environment.
Up to 10 bursaries will be awarded to assist members of the European Association for Cancer Research to attend the symposium. The bursaries provide a registration and funds to support travel and accommodation.
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.